인체 탯줄유래 중간엽줄기세포의 모발 유도능 평가
분야
의약학 > 의공학
저자
유보영 ( Bo Young Yoo ) , 신연호 ( Youn Ho Shin ) , 윤희훈 ( Hee Hoon Yoon ) , 김영진 ( Young Jin Kim ) , 서영권 ( Young Kwon Seo ) , 송계용 ( Kye Yong Song ) , 박정극 ( Jung Keug Park )
발행기관
한국조직공학·재생의학회
간행물정보
조직공학과 재생의학 2009년, 제6권 제1호, 15~22페이지(총8페이지)
파일형식
2a800307.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    4,500원
    적립금
    135원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Alopecia is the medical description of the loss of hair from the head or body. Alopecia tends to be involuntary and unwelcome. Alopecia does not vitally influence one`s life but patients who undergo alopecia appeal severe mental stress. The number of alopecia patients increases steadily. The current therapies used for treating alopecia have a number of limitations and to overcome such problems, many researchers have attempted to revive hair follicles by in vitro culturing hair follicle cells and implanting them in the treatment area. In this study, umbilical cord-derived mesenchymal stem cells(UC-MSCs) could be isolated and expanded successfully from the Wharton`s Jelly. Culture-expanded UC-MSCs formed aggregates similar to native dermal papilla(DP) in size and morphology under the special medium. Also the aggregates showed similar protein expression pattern of primary dermal papilla cells(DPCs). To confirm whether the aggregates could induce hair follicle instead of DP, they were transplanted with outer root sheath cells(ORSCs) in athymic nude mice`s inner-dermis where cells underwent proliferation and differentiation. After 6 weeks of transplantation, we observed new hairs on the mice`s scalp apparently. In conclusion, our results suggest that UC-MSC would be one of the cell sources for the treatment of alopecia in the future.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.